Trial Profile

To assess two different treatment schedules (monthly or biweekly) according to subjects' baseline 25(OH)D level in terms of the percentage of adult population with vitamin D defici ency (25(OH)D <20 ng/mL) who achieved plasmatic levels within the optimal range (20-60 ng/mL) after a 4-month treatment with calcifediol

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Aug 2022 New trial record
28 Jun 2022 Interim results (n=79) presented at the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2022

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com